Onyx @ Union Square: Helmy Eltoukhy, CEO, Guardant Health
Blood tests for cancer are here, and Guardant Health is leading the charge.
Blood tests for cancer are here, and Guardant Health is leading the charge.
Guardant Health has seen a string of consistent firsts - most recently FDA approval for colorectal cancer in July, 2024